November 15, 2011
You’ve probably noticed your cell phone and computer give off an eerie blue color in the dark.
Dr. Russell Rosenberg, CEO of the Atlanta Sleep Medicine Clinic, sat down with Fox5 to discuss how something that small may be keeping you up at night.
“In that hour before bedtime, there are millions of Americans who are getting exposed to bright light, blue light from their computer screens or television screens,” said Dr. Rosenberg.
Watch the full interview here.
November 9, 2011
NeuroTrials Research has begun enrolling qualified participants for a Multiple Sclerosis study. The study will last 96 weeks and will consist of only 11 office visits. NeuroTrials is excited to share this particular MS study with you because it is a comparison study rather than a placebo study. This means that qualified participants will definitely receive one of two MS drugs – either the new study drug, or an existing FDA approved drug that serves as the “control” comparison.
- Diagnosis of Multiple Sclerosis (cannot be primary progressive MS)
- Ages 18-55
- At least 2 documented clinical “attacks” (relapses/worsening of symptoms) within the last 2 years OR 1 clinical attack in past year.
- Documented MRI of brain with abnormalities consistent with MS prior to screening.
- Diagnosis of primary progressive MS
- Known presence of other neurological disorders which may mimic MS (Myasthenia Gravis, Lupus, Fibromyalgia)
- Known active infection or other infections such as herpes, mono, epstein barr virus, yeast infection, flu, strep, TB, HIV, and infection other than toenail fungus.
- History of cancer (other than some minor skin cancers)
Participants will be seen by the investigating neurologist and our staff for study purposes only. All study-related office visits, medical examinations, and study medication will be provided to qualified study participants at no cost. Compensation is also available for the patient’s time and travel.
If you or someone you know may be interested in participating, contact us at (404) 851-9934 for more information or an initial screening over the phone. You can also contact us through our website www.neurotrials.com.
While there is still no cure for Multiple Sclerosis, participating in clinical trials can help researchers better understand and develop new treatments for this condition. Help us keep MS research moving!